{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:55:34Z","timestamp":1791111334672,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T00:00:00Z","timestamp":1267488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>The major drug\u2010metabolizing enzymes for the oxidation of oxycodone are CYP2D6 and CYP3A. A high interindividual variability in the activity of these enzymes because of genetic polymorphisms and\/or drug\u2013drug interactions is well established. The possible role of an active metabolite in the pharmacodynamics of oxycodone has been questioned and the importance of CYP3A\u2010mediated effects on the pharmacokinetics and pharmacodynamics of oxycodone has been poorly explored.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>We conducted a randomized crossover (five arms) double\u2010blind placebo\u2010controlled study in 10 healthy volunteers genotyped for CYP2D6. Oral oxycodone (0.2\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>) was given alone or after inhibition of CYP2D6 (with quinidine) and\/or of CYP3A (with ketoconazole). Experimental pain (cold pressor test, electrical stimulation, thermode), pupil size, psychomotor effects and toxicity were assessed.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>CYP2D6 activity was correlated with oxycodone experimental pain assessment. CYP2D6 ultra\u2010rapid metabolizers experienced increased pharmacodynamic effects, whereas cold pressor test and pupil size were unchanged in CYP2D6 poor metabolizers, relative to extensive metabolizers. CYP2D6 blockade reduced subjective pain threshold (SPT) for oxycodone by 30% and the response was similar to placebo. CYP3A4 blockade had a major effect on all pharmacodynamic assessments and SPT increased by 15%. Oxymorphone C<jats:sub>max<\/jats:sub>was correlated with SPT assessment (\u03c1<jats:sub>S<\/jats:sub>= 0.7) and the only independent positive predictor of SPT. Side\u2010effects were observed after CYP3A4 blockade and\/or in CYP2D6 ultra\u2010rapid metabolizers.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>The modulation of CYP2D6 and CYP3A activities had clear effects on oxycodone pharmacodynamics and these effects were dependent on CYP2D6 genetic polymorphism.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00709.x","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T11:11:57Z","timestamp":1267528317000},"page":"919-930","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety"],"prefix":"10.1111","volume":"160","author":[{"given":"CF","family":"Samer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Daali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hopfgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CB","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"Rebsamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MF","family":"Rossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hochstrasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(96)00212-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.12.3.163"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0022-3565(24)36560-7","article-title":"Pharmacogenetic determinants of codeine induction by rifampin: the impact on codeine's respiratory, psychomotor and miotic effects","volume":"281","author":"Caraco Y","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90150-A"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90142-0"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0022-3565(25)24040-X","article-title":"The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague\u2010Dawley\/Dark Agouti rat model","volume":"271","author":"Cleary J","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_8_1","first-page":"451","article-title":"Oxycodone. Pharmacological profile and clinical data in chronic pain management","volume":"71","author":"Coluzzi F","year":"2005","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0090-9556(25)08048-1","article-title":"Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog","volume":"11","author":"Cone EJ","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.11.019"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-002-0385-9"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000085421.74359.60"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03004033"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0762-z"},{"key":"e_1_2_8_15_1","first-page":"381","article-title":"Eukodal ein neues Narkoticum","volume":"20","author":"Falk E","year":"1917","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2007.00153.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.39.11.1071"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041888"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0568-5"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20893"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90051-0"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01745.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90156-X"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90024-7"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.4.447"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.01.009"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.11.030"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000205751.88422.41"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200610000-00027"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(96)00050-4"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.12.065"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31819faa54"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0657-0"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.01.021"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.43"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2008.7"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122009926"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00093-6"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03021775"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.3.3.239"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00673.x"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2005.11.003"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000265176.75372.ed"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.03.018"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.009738"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.058602"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)91055-N"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.037549"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00378.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00709.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00709.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T22:53:08Z","timestamp":1739919188000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00709.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,24]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00709.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00709.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,24]]},"assertion":[{"value":"2010-05-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}